What Vera Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 2 | 25 |
| Total trades | 6 | 46 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 46 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO | Sep 15 | Open-market sale · S | −18,500 | $37.00 | −$685K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | Sep 15 | Exercise / conversion · M | +18,500 | $2.90 | +$53.6K | 253,744 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sep 11 | Exercise / conversion · M | +5,000 | $3.94 | +$19.7K | 80,754 |
| Fordyce Marshall | PRESIDENT AND CEO | Sep 02 | Open-market sale · S | −18,500 | $35.12 | −$650K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | Sep 02 | Exercise / conversion · M | +18,500 | $2.90 | +$53.6K | 253,744 |
| Boman Nancy Lee | Chief Regulatory Officer | Aug 03 | Grant / award · A | +44,987 | — | — | 44,987 |
| Fordyce Marshall | PRESIDENT AND CEO | Jul 07 | Open-market sale · S | −2,200 | $43.59 | −$95.9K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | Jul 07 | Open-market sale · S | −10,500 | $42.86 | −$450K | 237,444 |
| Fordyce Marshall | PRESIDENT AND CEO | Jul 07 | Open-market sale · S | −32,550 | $42.07 | −$1.37M | 247,944 |
| Fordyce Marshall | PRESIDENT AND CEO | Jul 07 | Open-market sale · S | −1,000 | $40.78 | −$40.8K | 280,494 |
| Fordyce Marshall | PRESIDENT AND CEO | Jul 07 | Exercise / conversion · M | +46,250 | $2.90 | +$134K | 281,494 |
| Fordyce Marshall | PRESIDENT AND CEO | Jun 23 | Open-market sale · S | −88 | $38.43 | −$3.38K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | Jun 23 | Open-market sale · S | −18,412 | $37.93 | −$698K | 235,332 |
| Fordyce Marshall | PRESIDENT AND CEO | Jun 23 | Exercise / conversion · M | +18,500 | $2.90 | +$53.6K | 253,744 |
| Fordyce Marshall | PRESIDENT AND CEO | May 12 | Open-market sale · S | −4,281 | $37.09 | −$159K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | May 12 | Open-market sale · S | −14,219 | $36.64 | −$521K | 239,525 |
| Fordyce Marshall | PRESIDENT AND CEO | May 12 | Exercise / conversion · M | +18,500 | $2.90 | +$53.6K | 253,744 |
| Fordyce Marshall | PRESIDENT AND CEO | Apr 14 | Open-market sale · S | −900 | $45.51 | −$41K | 235,244 |
| Fordyce Marshall | PRESIDENT AND CEO | Apr 14 | Open-market sale · S | −7,921 | $44.58 | −$353K | 236,144 |
| Fordyce Marshall | PRESIDENT AND CEO | Apr 14 | Open-market sale · S | −14,130 | $43.66 | −$617K | 244,065 |
Loading...
